(Q46886397)

26 December 2017

title

Renoprotective effect of a dopamine D3 receptor antagonist in experimental type II diabetes (English)

1 reference

26 December 2017

0 references

4

Marcin Adamczak

1 reference

26 December 2017

author name string

Marie-Luise P Gross

1

1 reference

26 December 2017

Andreas Koch

2

1 reference

26 December 2017

Bernd Mühlbauer

3

1 reference

26 December 2017

Heike Ziebart

5

1 reference

26 December 2017

Karla Drescher

6

1 reference

26 December 2017

Gerhard Gross

7

1 reference

26 December 2017

Irina Berger

8

1 reference

26 December 2017

Kerstin U Amann

9

1 reference

26 December 2017

Eberhard Ritz

10

1 reference

26 December 2017

publication date

1 March 2006

1 reference

26 December 2017

published in

Laboratory Investigation

1 reference

26 December 2017

volume

86

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

262-274

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/labinvest.3700383

exact match

0 references

cites work

Renal damage in the SHR/N-cp type 2 diabetes model: comparison of an angiotensin-converting enzyme inhibitor and endothelin receptor blocker

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on blood pressure and the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

Dopamine D1A receptors and renin release in rat juxtaglomerular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

Dopamine D2-like receptors and amino acid-induced glomerular hyperfiltration in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

Reduction of glomerular hyperfiltration by dopamine D(2)-like receptor blockade in experimental diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

Role of growth hormone in the development of experimental renal scarring

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

Contribution of tubular injury to loss of remnant kidney function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

Glomerulosclerosis and progression: effect of subantihypertensive doses of alpha and beta blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

Disruption of the dopamine D3 receptor gene produces renin-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

Abnormal adrenal catecholamine synthesis in salt-sensitive Dahl rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

Lack of renal dopamine production during acute volume expansion in Dahl salt-sensitive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

Dopamine D(3) receptors in the rat kidney: role in physiology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

Effect of dopamine D3 receptor blockade on renal function and glomerular size in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

Expression of the dopamine D3 receptor protein in the rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

Pharmacological characterisation and autoradiographic localisation of a putative dopamine D3 receptor in the rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

Dopamine attenuates the contractile response to angiotensin II in isolated rat glomeruli and cultured mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

cAMP pathway in podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

21 January 2018

Leptin and renal disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-beta type II receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

Leptin enhances the effect of transforming growth factor beta in increasing type I collagen formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

Postglomerular vasoconstriction induced by dopamine D(3) receptor activation in anesthetized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

7 January 2021

Effect of genetic dilution on development of diabetes, impaired glucose tolerance and in vitro glucose oxidation in LA/N-cp x SHR/N-cp F1 hybrid rats

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

7 January 2021

Calcium blockade versus ACE inhibition in clipped and unclipped kidneys of 2K-1C rats

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

7 January 2021

Measuring through the microscope: development and evolution of stereological methods

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

7 January 2021

Angiotensin converting-enzyme inhibitor treatment reduces glomerular p16INK4 and p27Kip1 expression in diabetic BBdp rats

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

7 January 2021

C-type natriuretic peptide inhibits mesangial cell proliferation and matrix accumulation in vivo

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

7 January 2021

High altitude-induced albuminuria in normal man is enhanced by infusion of low-dose dopamine

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

7 January 2021

Hypoxia-induced changes in extracellular matrix metabolism in renal cells

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

7 January 2021

Impaired intrarenal dopamine production following intravenous sodium chloride infusion in Type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

7 January 2021

The dopaminuric response to high salt diet in insulin-dependent diabetes mellitus and in family history of hypertension

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

7 January 2021

Predicting diabetic nephropathy in insulin-dependent patients

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

7 January 2021

Association of prolonged hyperglycemia with glomerular hypertrophy and renal basement membrane thickening in the Goto Kakizaki model of non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

7 January 2021

Progression of chronic renal disease

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3700383

7 January 2021

10.1038/LABINVEST.3700383

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017